New York, NY, United States of America

Yuliang Liu

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuliang Liu. Retrieved from https://idiyas.com/inventor/yuliang-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuliang Liu: Innovator in Pharmaceutical Chemistry

Introduction

Yuliang Liu is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Yuliang Liu holds a patent for "Naphthoquinones, pro-drugs, and methods of use thereof." This patent includes naphthoquinone compounds that feature a hydrogen bond donating group. The compounds are designed for use in pharmaceutical compositions and methods of treatment, including applications in cancer therapy.

Career Highlights

Yuliang Liu is affiliated with the University of Texas System, where he continues to advance research in pharmaceutical sciences. His work focuses on innovative approaches to drug development and treatment methodologies.

Collaborations

He has collaborated with notable colleagues such as Jinming Gao and Qi Wei, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yuliang Liu's work exemplifies the intersection of chemistry and medicine, showcasing the potential of his inventions to impact cancer treatment. His contributions to the field are invaluable and highlight the importance of ongoing research in pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…